vs
Assertio Holdings, Inc.（ASRT）与Aterian, Inc.（ATER）财务数据对比。点击上方公司名可切换其他公司
Aterian, Inc.的季度营收约是Assertio Holdings, Inc.的1.1倍（$15.1M vs $13.5M），Aterian, Inc.同比增速更快（-38.5% vs -57.9%），过去两年Aterian, Inc.的营收复合增速更高（-13.5% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Aterian, Inc.是一家技术驱动的消费品企业，依托人工智能与数据分析挖掘市场需求，开发、采购并销售家居、个护、健康、户外、宠物用品等多品类高性价比商品，主要通过全球主流电商平台销往北美、欧洲等核心市场。
ASRT vs ATER — 直观对比
营收规模更大
ATER
是对方的1.1倍
$13.5M
营收增速更快
ATER
高出19.4%
-57.9%
两年增速更快
ATER
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $15.1M |
| 净利润 | — | $-7.9M |
| 毛利率 | — | 56.1% |
| 营业利润率 | -86.7% | -51.1% |
| 净利率 | — | -52.5% |
| 营收同比 | -57.9% | -38.5% |
| 净利润同比 | — | -512.2% |
| 每股收益（稀释后） | $-4.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTATER
| Q4 25 | $13.5M | $15.1M | ||
| Q3 25 | $49.5M | $19.0M | ||
| Q2 25 | $29.2M | $19.5M | ||
| Q1 25 | $26.5M | $15.4M | ||
| Q4 24 | $32.2M | $24.6M | ||
| Q3 24 | $29.2M | $26.2M | ||
| Q2 24 | $31.1M | $28.0M | ||
| Q1 24 | $32.4M | $20.2M |
净利润ASRTATER
| Q4 25 | — | $-7.9M | ||
| Q3 25 | $11.4M | $-2.3M | ||
| Q2 25 | $-16.4M | $-4.9M | ||
| Q1 25 | $-13.5M | $-3.9M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | $-2.9M | $-1.8M | ||
| Q2 24 | $-3.7M | $-3.6M | ||
| Q1 24 | $-4.5M | $-5.2M |
毛利率ASRTATER
| Q4 25 | — | 56.1% | ||
| Q3 25 | — | 56.1% | ||
| Q2 25 | — | 54.3% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | — | 63.4% | ||
| Q3 24 | — | 60.3% | ||
| Q2 24 | — | 60.4% | ||
| Q1 24 | — | 65.1% |
营业利润率ASRTATER
| Q4 25 | -86.7% | -51.1% | ||
| Q3 25 | 23.2% | -10.7% | ||
| Q2 25 | -27.5% | -23.1% | ||
| Q1 25 | -50.0% | -24.1% | ||
| Q4 24 | -41.9% | -6.5% | ||
| Q3 24 | -10.4% | -6.6% | ||
| Q2 24 | -11.6% | -11.5% | ||
| Q1 24 | -13.4% | -26.1% |
净利率ASRTATER
| Q4 25 | — | -52.5% | ||
| Q3 25 | 23.1% | -12.0% | ||
| Q2 25 | -56.0% | -25.0% | ||
| Q1 25 | -51.1% | -25.4% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | -10.0% | -6.8% | ||
| Q2 24 | -11.8% | -13.0% | ||
| Q1 24 | -13.9% | -25.5% |
每股收益（稀释后）ASRTATER
| Q4 25 | $-4.54 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $4.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $15.2M |
| 总资产 | $267.0M | $29.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTATER
| Q4 25 | $63.4M | $4.9M | ||
| Q3 25 | $93.4M | $7.6M | ||
| Q2 25 | $98.2M | $10.5M | ||
| Q1 25 | $87.3M | $14.3M | ||
| Q4 24 | $100.1M | $18.0M | ||
| Q3 24 | $88.6M | $16.1M | ||
| Q2 24 | $88.4M | $20.3M | ||
| Q1 24 | $80.7M | $17.5M |
总债务ASRTATER
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTATER
| Q4 25 | $94.0M | $15.2M | ||
| Q3 25 | $105.8M | $22.6M | ||
| Q2 25 | $93.3M | $24.3M | ||
| Q1 25 | $108.5M | $27.0M | ||
| Q4 24 | $121.1M | $30.0M | ||
| Q3 24 | $130.5M | $30.6M | ||
| Q2 24 | $132.2M | $30.9M | ||
| Q1 24 | $134.5M | $33.0M |
总资产ASRTATER
| Q4 25 | $267.0M | $29.6M | ||
| Q3 25 | $319.8M | $40.1M | ||
| Q2 25 | $273.8M | $45.4M | ||
| Q1 25 | $286.4M | $49.8M | ||
| Q4 24 | $284.7M | $49.5M | ||
| Q3 24 | $276.0M | $52.1M | ||
| Q2 24 | $279.4M | $59.9M | ||
| Q1 24 | $282.0M | $55.7M |
负债/权益比ASRTATER
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-1.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.0M |
| 自由现金流率自由现金流/营收 | — | -6.9% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTATER
| Q4 25 | $-30.0M | $-1.0M | ||
| Q3 25 | $-4.8M | $-1.6M | ||
| Q2 25 | $19.1M | $-4.4M | ||
| Q1 25 | $-12.5M | $-3.9M | ||
| Q4 24 | $11.5M | $-9.0K | ||
| Q3 24 | $-35.0K | $-722.0K | ||
| Q2 24 | $7.4M | $2.9M | ||
| Q1 24 | $7.5M | $-6.0K |
自由现金流ASRTATER
| Q4 25 | — | $-1.0M | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $-4.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | — | $-42.0K |
自由现金流率ASRTATER
| Q4 25 | — | -6.9% | ||
| Q3 25 | — | -8.4% | ||
| Q2 25 | — | -22.7% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.2% |
资本支出强度ASRTATER
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.2% |
现金转化率ASRTATER
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
